globenewswire.com · 18 jun

ADT Earns Two 2026 Buyer's Choice Awards from ConsumerAffairs, Based on Customer Reviews

BOCA RATON, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), the leader in smart home security solutions, has earned two 2026 Buyer's Choice Awards from ConsumerAffairs, a leading platform for verified consumer reviews.

globenewswire.com · 17 jun

ADT Joins Board of Directors of the Connectivity Standards Alliance, Reinforcing Its Role in Shaping the Future of the Connected Home

BOCA RATON, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), the leader in smart home security solutions, today announced it has joined the Board of Directors of the Connectivity Standards Alliance (CSA), the global organization behind Matter, Zigbee and Aliro, foundational standards shaping the future of connected living.

zacks.com · 17 jun

Should Value Investors Buy ADT (ADT) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

seekingalpha.com · 10 jun

Buy 2 Ideal June DiviDogs Per Barron's April To June Picks

Barron's April–June 2026 stock picks highlight 32 names, with a focus on 19 high-yield, dividend-paying equities subjected to contrarian 'dogcatcher' analysis. Top ten dividend stocks yield 1.33%–5.16%, with Build-A-Bear (BBW) and Kingstone (KINS) showing standout projected returns of 82.16% and 239.6%, respectively. CBL & Associates (CBL) and ADT Inc. (ADT) are identified as 'safer' ideal dividend dogs, with dividends from $1K invested exceeding their share prices.

zacks.com · 1 jun

Are Investors Undervaluing ADT (ADT) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

gurufocus.com · 31 may

Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm

Johnson and Johnson's Phase 3 prostate cancer study shows ERLEADAÂ (apalutamide) before and after surgery significantly reduces risk of metastas

zacks.com · 28 may

ADT (ADT) Upgraded to Buy: Here's Why

ADT (ADT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

cnet.com · 21 may

ADT Announces Yet Another DIY Home Security Line, Now With AI Features

ADT Blu shouldn't be confused with Blue by ADT, or ADT Self Setup. I know, it's a mess.